Low-dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation.
Oberkofler CE, Raptis DA, Müller PC, Sousa da Silva RX, Lehmann K, Ito T, Owen T, Pollok JM, Parente A, Schlegel A, Peralta P, Winter E, Selzner M, Fodor M, Maglione M, Jaklitsch M, Marques HP, Chavez-Villa M, Contreras A, Kron P, Lodge P, Alford S, Rana A, Magistri P, Di Benedetto F, Johnson B, Kirchner V, Bauldrick F, Halazun KJ, Ghamarnedjad O, Mehrabi A, Basto ST, Fernandes ESM, Paladini J, de Santibañes M, Florman S, Tabrizian P, Dutkowski P, Clavien PA, Busuttil RW, Kaldas FM, Petrowsky H.
Oberkofler CE, et al. Among authors: halazun kj.
Liver Transpl. 2022 Dec;28(12):1888-1898. doi: 10.1002/lt.26534. Epub 2022 Aug 5.
Liver Transpl. 2022.
PMID: 35735232
Free PMC article.